What is Jiangxi Xinganjiang Pharmaceutical Co OCF Margin %?
Jiangxi Xinganjiang Pharmaceutical CoBJSE:920367 60 OCF Margin % is 15.51% as of Mar. 2026, which is 48% below its 10-year median of 29.90. GuruFocus rates BJSE:920367 with a GF Score™ of 60/100 and a GF Value™ of ¥12.14 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 961 Drug Manufacturers companies, Jiangxi Xinganjiang Pharmaceutical Co ranks better than 67.33% on this metric.
BJSE:920367'
s OCF Margin % Range Over the Past 10 Years
Min: 9.64 Med: 29.9 Max: 90.88
Current: 15.72
During the past 10 years, the highest OCF Margin % of Jiangxi Xinganjiang Pharmaceutical Co was 90.88%. The lowest was 9.64%. And the median was 29.90%.
BJSE:920367's OCF Margin % is ranked better than 67.33% of 961
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs BJSE:920367: 15.72
Jiangxi Xinganjiang Pharmaceutical Co OCF Margin % Related Terms
Jiangxi Xinganjiang Pharmaceutical Co OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Xinganjiang Pharmaceutical Co OCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangxi Xinganjiang Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangxi Xinganjiang Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangxi Xinganjiang Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Jiangxi Xinganjiang Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) has a OCF Margin % of 15.51% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. This is 48% below median its historical median of 29.90. Over the past decade, Jiangxi Xinganjiang Pharmaceutical Co's OCF Margin % has ranged from 9.64 to 90.88. According to the industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #314 out of 961 companies in the Drug Manufacturers industry, placing it in the top 32.7%.
Is Jiangxi Xinganjiang Pharmaceutical Co's OCF Margin % too high?
Jiangxi Xinganjiang Pharmaceutical Co's current OCF Margin % of 15.51% is 48% below median its 10-year median of 29.90. Over the past 10 years, this metric has ranged from a low of 9.64 to a high of 90.88. The Drug Manufacturers industry median OCF Margin % is 9.94. Jiangxi Xinganjiang Pharmaceutical Co's value of 15.51% is 56% above this industry median. Based on the distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #314 out of 961 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jiangxi Xinganjiang Pharmaceutical Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Xinganjiang Pharmaceutical Co's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #314 out of 961 companies for OCF Margin %. This puts Jiangxi Xinganjiang Pharmaceutical Co in the upper half of its industry. The industry median OCF Margin % is 9.94. Jiangxi Xinganjiang Pharmaceutical Co's value of 15.51% is 56% above this benchmark. Historically, Jiangxi Xinganjiang Pharmaceutical Co's own OCF Margin % has ranged from 9.64 to 90.88 over the past decade. While the company's 10-year median is 29.90 vs. the industry median of 9.94, Jiangxi Xinganjiang Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangxi Xinganjiang Pharmaceutical Co's current OCF Margin % of 15.51% is 56% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangxi Xinganjiang Pharmaceutical Co's current OCF Margin % is 15.51%, which is 48% below median its own 10-year median of 29.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Xinganjiang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥12.14, compared to a current price of ¥21.80 — trading 79.6% above its estimated fair value. The current OCF Margin % is 15.51%, which is 48% below median its 10-year median of 29.90 and 56% above the Drug Manufacturers industry median of 9.94. Jiangxi Xinganjiang Pharmaceutical Co's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367), the current OCF Margin % is 15.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥21.80 is trading 79.6% above its estimated GF Value™ of ¥12.14.
GuruFocus considers Jiangxi Xinganjiang Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for BJSE:920367:
OCF Margin %: 15.51% (48% below median its 10-year median of 29.90)
GF Value™: ¥12.14 vs. price of ¥21.80 (79.6% above fair value)
Industry Position: 56% above the Drug Manufacturers median (#314 of 961)
No single metric tells the full story. See the BJSE:920367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangxi Xinganjiang Pharmaceutical Co Business Description
Jiangxi Xinganjiang Pharmaceutical Co Ltd conducts research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate, and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, and Phenaminokamin Tablets.
60GF Score
Get the complete analysis for BJSE:920367
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920367 has been successfully added to your 
